Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | LAP3 | P28838 | 3/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.40 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.40 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | GRN | P28799 | 1/20 | 0.36 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12481793 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TGFBR1MEN1LMNAKMT2A | |
| SCHEMBL5186755 | 0.81 | TGFBR1 (0.67) | ALDH1A1TGFBR1MAPTMMEGRN | |
| SCHEMBL6242220 | 0.81 | TGFBR1 (0.67) | ALDH1A1TGFBR1MEN1LMNAKMT2A | |
| SCHEMBL8032842 | 0.81 | TGFBR1 (0.67) | ALDH1A1TGFBR1MEN1LMNAKMT2A | |
| SCHEMBL5186759 | 0.81 | TGFBR1 (0.67) | ALDH1A1TGFBR1MAPTMMEGRN | |
| SCHEMBL27877720 | 0.81 | ALDH1A1 (0.64) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL30164504 | 0.81 | ALDH1A1 (0.64) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL30066898 | 0.80 | TGFBR1 (0.50) | ALDH1A1TGFBR1MAPTMMEGRN | |
| SCHEMBL30211920 | 0.78 | ALDH1A1 (0.64) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL28875839 | 0.77 | TGFBR1 (0.47) | ALDH1A1TGFBR1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12329833-B2 | Dental compositions | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-06-17 | — | — | US | disclosed |
| US-20250049644-A1 | Dental Compositions | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-02-13 | — | — | US | disclosed |
| EP-4444250-A1 | DENTAL COMPOSITIONS | Solventum Intellectual Properties Company (US) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023105315-A1 | DENTAL COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-06-15 | — | — | WO | disclosed |
| EP-2726049-B1 | DENTAL COMPOSITIONS COMPRISING A FATTY MONO(METH)ACRYLATE | 3M INNOVATIVE PROPERTIES CO (US) | 2022-08-17 | — | — | EP | disclosed |
| EP-2675422-B1 | DENTAL COMPOSITIONS COMPRISING ETHYLENICALLY UNSATURATED ADDITION-FRAGMENTATION AGENT | 3M INNOVATIVE PROPERTIES CO (US) | 2020-09-30 | — | — | EP | disclosed |
| EP-2965742-B1 | DENTAL COMPOSITIONS COMPRISING ETHYLENICALLY UNSATURATED ADDITION-FRAGMENTATION AGENT | 3M INNOVATIVE PROPERTIES CO (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-2552380-B1 | POLYMERIZABLE ISOCYANURATE MONOMERS AND DENTAL COMPOSITIONS | 3M INNOVATIVE PROPERTIES CO (US) | 2019-04-24 | — | — | EP | disclosed |
| US-10022306-B2 | Dental compositions comprising a fatty mono(meth)acrylate | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-17 | — | — | US | disclosed |
| US-20160361238-A1 | DENTAL COMPOSITIONS COMPRISING A FATTY MONO(METH)ACRYLATE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-12-15 | — | — | US | disclosed |
| US-20140099271-A1 | DENTAL COMPOSITIONS COMPRISING A FATTY MONO(METH)ACRYLATE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-04-10 | — | — | US | disclosed |
| EP-2675421-A2 | DENTAL COMPOSITIONS COMPRISING MIXTURE OF ISOCYANURATE MONOMER AND TRICYCLODECANE MONOMER | 3M Innovative Properties Company (US) | 2013-12-25 | — | — | EP | disclosed |
| EP-2675422-A2 | DENTAL COMPOSITIONS COMPRISING ETHYLENICALLY UNSATURATED ADDITION-FRAGMENTATION AGENT | 3M Innovative Properties Company (US) | 2013-12-25 | — | — | EP | disclosed |
| US-20130316307-A1 | DENTAL COMPOSITIONS COMPRISING ETHYLENICALLY UNSATURATED ADDITION-FRAGMENTATION AGENT | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-11-28 | — | — | US | disclosed |
| EP-2552380-A2 | POLYMERIZABLE ISOCYANURATE MONOMERS AND DENTAL COMPOSITIONS | 3M Innovative Properties Company (US) | 2013-02-06 | — | — | EP | disclosed |
| US-20130012614-A1 | POLYMERIZABLE ISOCYANURATE MONOMERS AND DENTAL COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-01-10 | — | — | US | disclosed |
| WO-2013003396-A2 | DENTAL COMPOSITIONS COMPRISING A FATTY MONO(METH)ACRYLATE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-01-03 | — | — | WO | disclosed |
| WO-2012112350-A2 | DENTAL COMPOSITIONS COMPRISING ETHYLENICALLY UNSATURATED ADDITION-FRAGMENTATION AGENT | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-08-23 | — | — | WO | disclosed |
| WO-2012112321-A2 | DENTAL COMPOSITIONS COMPRISING MIXTURE OF ISOCYANURATE MONOMER AND TRICYCLODECANE MONOMER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-08-23 | — | — | WO | disclosed |
| WO-2011126647-A2 | POLYMERIZABLE ISOCYANURATE MONOMERS AND DENTAL COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049644-A1 | Dental Compositions | ARCN1, EEF1D, EBP | ALDH1A1 1021/4885TGFBR1 2683/4885MEN1 3821/4885 |
| US-12329833-B2 | Dental compositions | ARCN1, EEF1D, EBP | ALDH1A1 1021/4885TGFBR1 2683/4885MEN1 3821/4885 |
| US-20140099271-A1 | DENTAL COMPOSITIONS COMPRISING A FATTY MONO(METH)ACRYLATE | MMAB, ELOVL5, ELOVL1 | ALDH1A1 1066/4885TGFBR1 4493/4885MEN1 3593/4885 |
| US-20130012614-A1 | POLYMERIZABLE ISOCYANURATE MONOMERS AND DENTAL COMPOSITIONS | ETV6, PCMT1, MLLT1 | ALDH1A1 1402/4885TGFBR1 3413/4885MEN1 3082/4885 |
| US-20160361238-A1 | DENTAL COMPOSITIONS COMPRISING A FATTY MONO(METH)ACRYLATE | MMAB, ELOVL5, ELOVL1 | ALDH1A1 1066/4885TGFBR1 4493/4885MEN1 3593/4885 |
| US-10022306-B2 | Dental compositions comprising a fatty mono(meth)acrylate | MMAB, ELOVL5, ELOVL1 | ALDH1A1 1066/4885TGFBR1 4493/4885MEN1 3593/4885 |
| US-20130316307-A1 | DENTAL COMPOSITIONS COMPRISING ETHYLENICALLY UNSATURATED ADDITION-FRAGMENTATION AGENT | RXRA, RXRG, NR4A1 | ALDH1A1 1884/4885TGFBR1 899/4885MEN1 2319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.